Replies to post #524799 on NorthWest Biotherapeutics Inc (NWBO)

[Fireman02360]

I understand that we are now so far into that process that the scenario of it getting ‘shelved’ is non-existent

DC Vax was never going to get shelved, ever. So long as the Phase 3 trial was a success.....and it was, big time. Sure, the makers of Chemo and other cancer drugs might not want to give up the profits and not see DC Vax go commercial, but there is always another drug Company that may not have a strong foot-print in Oncology, but wants one, that would bring the drug to market. These people are very smart. I am not into conspiracy theories regrading shelving drugs by BP. I do believe the Financial/ WS Industry try to suffocate smaller Biotechs for financial gain because of financial interests in the same indication or space. Wall Street is a criminal enterprise, plain and simple. I have friends who are in some pretty high places in NYC and Boston who work in this field. Its ALL about money, not morals. I can tell you this stuff can and does happen. Last weeks information, while visiting a friend on Fire Island, was proof of it.

-Fireman

[skitahoe]

VI,

I believe that what you're saying is equally true about Institutional Investors. In some cases they may be getting in the beginning of a quarter and out by the end, so they don't need to report, but largely they're waiting. I believe that some are waiting just for higher share prices, in the $2 to $5 range, still others insist on both the higher price and the move to a major exchange.

Once we've seen $4 or more I believe they'll work to move to a major exchange, I believe it's possible rather quickly but the exchange may have to waive some requirements to really expedite it. I believe the news from the company may be so strong that it will be highly desirable to have NWBO in your exchange and both NYSE and Nasdaq may be willing to expedite an application from NWBO.

I previously guessed that a partnership or buyout starts to become possible once our share price is roughly $8 or more which should take our market cap into double digits. If prior indications from posters about L.P. not considering anything under a valuation of $20 billion, that size an offer is possible once our market cap is above $10 billion which ought to occur in the $8 range, depending on how many shares have been issued at that time.

I believe that our share price will grow dramatically once we reach a range where Institutions start moving in. By the time we're in double digits I'd not be surprised to have 50% or greater ownership by Institutions.

Gary

[dr_lowenstein]

really?which companies?